Back to Search Start Over

Primary therapy of Waldenström macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)

Authors :
Dimopoulos, Meletios A Garca-Sanz, Ramón Gavriatopoulou, Maria Morel, Pierre Kyrtsonis, Marie-Christine Michalis, Eurydiki Kartasis, Zafiris Leleu, Xavier Palladini, Giovanni Tedeschi, Alessandra others
Publication Year :
2013

Subjects

Subjects :
Health Sciences
Επιστήμες Υγείας

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..104e8485f2862e56899a47d2a1827d62

Tools

Authors Abstract Subjects Details